AdvaMed Advocates for Medtech-Centered Privacy Protections
In response to the House Energy & Commerce Committee Privacy Working Group’s Request for Information,AdvaMed® outlines how federal privacy legislation must account for the unique nature of medical device data. This public comment highlights the critical distinctions between clinician-operated medtech and consumer health data tools, and calls for a tailored, innovation-friendly approach to protecting patient privacy while enabling life-saving technologies.
Related Reading
Resource / Legal
AdvaMed Comment Letter to OIG’s RFI on Clinical Trial Remuneration and Fraud & Abuse Laws
September 11, 2026
AdvaMed urges OIG to modernize Anti-Kickback Statute and Beneficiary Inducements CMP rules with a clinical trial-specific safe harbor to provide greater clarity for reasonable participant remuneration and support arrangements.
Event / Digital Health / Regulatory Affairs
Shifting Customer Engagement Models in Diagnostics: Winning in a Rapidly Evolving Market
September 29, 2026
2:00 PM – 3:00 PM
Join Deloitte in this discussion examining how rising consumer expectations, new technology entrants, and evolving provider roles are reshaping how diagnostics manufacturers engage their customers.
Event / Digital Health / Regulatory Affairs
Reimagining the Cost of Quality: The Agentic AI Opportunity for MedTech
September 30, 2026 10:00AM – 11:00AM ET
Join HCLTech in this discussion about practical use cases and strategies to scale AI-driven quality operations while maintaining compliance and enabling greater innovation.
Blog / Artificial Intelligence (AI) / Digital Health / Health Access
The Insight Series: AI & Digital Health with Kelly Huang
August 27, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. This edition features Kelly Huang, CEO of Elucid, an AI medical technology company focused on providing physicians with a more precise, non-invasive view of atherosclerosis to drive patient-specific cardiovascular care.
News / Diagnostics / Digital Health / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Statement on the Nomination of Dr. Heidi Overton as FDA Commissioner
August 19, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner.
Event / Digital Health / Regulatory Affairs
Software as a Medical Device: From Regulatory Strategy to Market Readiness
September 16, 2026
12:00 PM – 1:00 PM
Join MIDI as they provide a practical framework for developing SaMD products with regulatory requirements built into the development process.
Blog / Artificial Intelligence (AI) / Diagnostics / Digital Health / Health Access
The Insight Series: AI & Digital Health
July 27, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. Our latest edition features Jacque Engle, Vice President of Marketing & Communication and Juli Goldstein, Vice President of Government Affairs & Market Access at Digital Diagnostics.
Resource / Digital Health
From Mechanical Precision to Software Intelligence: How Medtech can follow Automotive’s Digital Transformation Playbook
July 21, 2026
In From Mechanical Precision to Software Intelligence, Kearney explores how MedTech companies can learn from the automotive industry’s shift to software-defined platforms. The article examines how connected devices, AI-enabled services, cloud-based capabilities, and recurring software revenues can help medical technology manufacturers improve customer value, accelerate innovation, and remain competitive in an increasingly digital healthcare landscape.